7:00 am ‐ 6:00 pm
7:00 am ‐ 8:45 am
Supported by an educational grant from Keryx Biopharmaceuticals, Inc.
7:00 am ‐ 7:30 am Breakfast Served
7:30 am ‐ 8:45 am Symposium
Rethinking Renal: A Multi-Disciplinary Approach to Treating Dialysis Patients in the Age of Bundled Care
8:45 am ‐ 9:45 am
Exhibits Open / Coffee Break
10:00 am ‐ 11:30 am
Glenda Payne, MS, RN, CNN
Understanding water treatment isn't just someone else's responsibility. It is important for the nurse and nurse manager to know key regulations. A comprehensive background on water treatment and how to respond to different issues that develop in daily situations will be provided through case studies.
Robin Trupp, PhD, ARNP, CHFN
Coronary artery disease (CAD) is prevalent in the CKD population. The methods of diagnosis are the same; however, the treatment parameters and strategies differ. This session will focus on strategies to halt the progression of CAD and a pharmacological plan of care for the patient with CAD and CKD.
Gerald Groggel, MD, FACP
Patients with HIV are living longer and receiving better regimens of therapy. What are the renal replacement treatment options that are best suited to the patient presenting with HIV nephropathy? Special considerations in the dually complex disease process of HIV treatment and CKD also will be discussed.
Kenneth Andreoni, MD
This in‐depth presentation will focus on kidney allocation policy changes, including the background of kidney allocation that led to these policy changes. What are the implications for the policy changes? How will these changes impact patients and their access to a transplant?
11:30 am ‐ 12:30 pm
Exhibits Open / Coffee Break
12:45 pm ‐ 2:30 pm
Supported by an educational grant from Sanofi Renal
12:45 pm ‐ 1:15 pm Luncheon Served
1:15 pm ‐ 2:30 pm Symposium
The Evidence Behind the Research: FGF-23 and Its Impact on CKD
Myles Wolf, MD, MMSC
2:45 pm ‐ 4:15 pm
Judie Bringhurst, MSN, RN, CIC
While we are never sure what the influenza season will bring, one thing is certain: the impact of the influenza virus has changed health care practices. What does this mean for health care workers? Is it ethical to make the flu vaccine mandatory for employment? Join us as we explore this topic as the flu season begins.
Brendan Bowman, MD
Vasoactive agents, whether resulting in dilation or constriction of the blood vessels, can cause issues in acute, chronic, CKD, and transplant patients. This session will explore these agents, the settings in which they are used, the pharmacokinetic properties, and the implications for practice.
Richard Hamburger, MD, FACP, FASN
In practice, the International Classification of Diseases (ICD) has provided an improved foundation to communicate precise details of patients and their medical conditions. It is also used to code and bill for these diseases. As the ICD system evolves and the newer ICD‐10 coding emerges, nephrology will need to examine the integral components of this new coding system and its impact on patient care.
Debra Hain, PhD, ANP-BC, GNP-BC
Evidence‐based practice is becoming more prevalent in health care today. Before we can implement a practice, nephrology nurses need to determine if an article is applicable to their practice setting. Learn from an expert researcher how to critique an article. See where the research was done well, and learn to evaluate research with a discerning eye.
4:30 pm ‐ 6:00 pm
Michelle Carver, BSN, RN, CNN
Telehealth has many implications in health care today — from being able to review a congestive heart failure patient's weight increases, to reviewing blood pressures, to assessing a patient with a portable monitoring system. What are the implications for nephrology? What are some of the scenarios where this equipment is currently being used in practice? Where can technology take us?
Spencer Galt, MD
We've all had those patients – they are a challenge to cannulate and have them run a good treatment, or our hearts race hoping all goes well with the first stick. Are there ways to improve the process? From determining access type to assessment to surgical creation and to the final line – the nurse is making the Olympic attempt. Learn about the surgical issues that can arise and how we as nurses can develop collaborative strategies for these difficult‐to‐approach accesses.
Heather Nyman, PharmD, BCPS
Newer, more resistance organisms develop, and newer, more potent antibiotics are created. What are some of the organisms that we are seeing in patient care settings, and what treatments are being developed to combat these bacteria? Differences in care relating to modality and to glomerular filtration rate also will be reviewed.
144HT1.5 CHEthical Principles and Moral Distress: Assisting Families with the Decision to Stop Dialysis for Their Loved Ones—A Case‐Based Approach
Phyllis Wille, MS, RN, FNP‐C, CNN
A dialysis patient wants to speak to you about helping them prepare their family. The patient is ready to "stop" dialysis, but their family is not. How do you have that conversation? Learn how to facilitate the discussion, while allowing the patient and family to voice their opinions and resolve this conflict in a manner that promotes dignity and respect for all parties.